Table 1.
Characteristics of cases and matched controls after breast cancer therapy in 1998–2008.
| Characteristics | Cases |
Controls |
||
|---|---|---|---|---|
| N = 494 | 100 (%c) | N = 988 | 100 (%c) | |
| Year of breast cancer diagnosis | ||||
| 1998–2000 | 62 | 12.55 | 129 | 13.06 |
| 2001–2003 | 94 | 19.03 | 182 | 18.42 |
| 2004–2006 | 213 | 43.12 | 441 | 44.64 |
| 2007–2008 | 125 | 25.30 | 236 | 23.89 |
| Age at breast cancer diagnosis | ||||
| Mean | 63.14 | / | 63.10 | / |
| SDa | 11.93 | / | 11.85 | / |
| Laterality | ||||
| Left | 264 | 53.44 | 540 | 54.66 |
| Right | 230 | 46.56 | 448 | 45.34 |
| T-stage | ||||
| 1 | 267 | 54.05 | 572 | 57.89 |
| 2 | 151 | 30.57 | 307 | 31.07 |
| 3 | 21 | 4.25 | 29 | 2.94 |
| 4 | 26 | 5.26 | 40 | 4.05 |
| In situ | 21 | 4.25 | 33 | 3.34 |
| Unknown | 8 | 1.62 | 7 | 0.71 |
| N-stage | ||||
| 0 | 311 | 62.96 | 586 | 59.31 |
| 1 | 111 | 22.47 | 248 | 25.10 |
| 2 | 34 | 6.88 | 77 | 7.79 |
| 3 | 15 | 3.04 | 45 | 4.55 |
| X | 23 | 4.66 | 32 | 3.24 |
| BMIb | ||||
| <25.0 | 207 | 41.90 | 411 | 41.60 |
| ≥25.0 | 253 | 51.21 | 509 | 51.52 |
| Unknown | 34 | 6.88 | 68 | 6.88 |
| History of cardiac diseased | ||||
| Yes | 84 | 17.00 | 168 | 17.00 |
| No/unknown | 410 | 83.00 | 820 | 83.00 |
| Chemotherapy | ||||
| Yes | 215 | 43.52 | 398 | 40.28 |
| No | 276 | 55.87 | 576 | 58.30 |
| Unknown | 3 | 0.61 | 14 | 1.42 |
| Endocrine therapy | ||||
| Yes | 382 | 77.33 | 745 | 75.40 |
| No | 98 | 19.84 | 201 | 20.34 |
| Unknown | 14 | 2.83 | 42 | 4.25 |
| Type of surgery | ||||
| Nonee | 3 | 0.61 | 1 | 0.10 |
| Breast conserving | 425 | 86.23 | 843 | 85.32 |
| Mastectomy | 66 | 13.36 | 144 | 14.57 |
| Unknown | 0 | 0.00 | 0 | 0.00 |
SD: Standard deviation.
BMI: Body Mass Index.
Percentages may not add up to a total of 100 due to rounding.
History of cardiac disease at the time of breast cancer diagnosis, including history of cardiac infarction, coronary heart disease, angina pectoris, NYHA≥3, dysrhythmia, vitium cordis or use of a pacemaker.
Patients who did not receive breast conserving surgery or mastectomy during their breast cancer therapy.